Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Drugs ; 17(7)2019 Jul 19.
Article in English | MEDLINE | ID: mdl-31331053

ABSTRACT

Low molecular weight fucoidan extract (LMF), prepared by an abalone glycosidase digestion of a crude fucoidan extracted from Cladosiphon novae-caledoniae Kylin, exhibits various biological activities, including anticancer effect. Various cancers express programmed cell death-ligand 1 (PD-L1), which is known to play a significant role in evasion of the host immune surveillance system. PD-L1 is also expressed in many types of normal cells for self-protection. Previous research has revealed that selective inhibition of PD-L1 expressed in cancer cells is critical for successful cancer eradication. In the present study, we analyzed whether LMF could regulate PD-L1 expression in HT1080 fibrosarcoma cells. Our results demonstrated that LMF suppressed PD-L1/PD-L2 expression and the growth of HT1080 cancer cells and had no effect on the growth of normal TIG-1 cells. Thus, LMF differentially regulates PD-L1 expression in normal and cancer cells and could serve as an alternative complementary agent for treatment of cancers with high PD-L1 expression.


Subject(s)
B7-H1 Antigen/antagonists & inhibitors , Fibrosarcoma/drug therapy , Phaeophyceae/chemistry , Plant Extracts/pharmacology , Polysaccharides/pharmacology , Apoptosis/drug effects , B7-H1 Antigen/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Fibrosarcoma/pathology , Humans , Molecular Weight , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Polysaccharides/chemistry , Polysaccharides/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...